Role in translation of a triple tandemly repeated sequence in the 5'-untranslated region of human thymidylate synthase mRNA.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Nucleic Acids Research

• Publication date

  1987-02-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/NAR/15.3.1259PMID 3029702PMCID PMC340522
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell cycle regulation of transfected murine dihydrofolate reductase genes.

  1986cited by this paper
• Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits.

  1985cited by this paper
• Expression of thymidine kinase and dihydrofolate reductase genes in mammalian ts mutants of the cell cycle.

  1985cited by this paper
• Transcriptional regulation of mouse dihydrofolate reductase in the cell cycle.

  1985cited by this paper
• Nucleotide sequence of a functional cDNA for human thymidylate synthase.

  1985cited by this paper
• Insertion mutagenesis to increase secondary structure within the 5' noncoding region of a eukaryotic mRNA reduces translational efficiency.

  1985cited by this paper
• Control of thymidylate synthase mRNA content and gene transcription in an overproducing mouse cell line

  1985cited by this paper
• Isolation of functional cDNA clones for human thymidylate synthase.

  1984cited by this paper
• Dihydrofolate reductase gene expression in cultured mouse cells is regulated by transcript stabilization in the nucleus

  1984cited by this paper
• Molecular cloning of genomic DNA segments partially coding for human thymidylate synthase from the mouse cell transformant.

  1984cited by this paper
• Cell cycle-dependent regulation of mammalian ribonucleotide reductase. The S phase-correlated increase in subunit M2 is regulated by de novo protein synthesis.

  1984cited by this paper
• Molecular cloning and cell cycle-specific regulation of a functional human thymidine kinase gene.

  1983cited by this paper
• A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells.

  1983cited by this paper
• Unusual aspects of human thymidylate synthase in mouse cells introduced by DNA-mediated gene transfer.

  1983cited by this paper
• Comparison of initiation of protein synthesis in procaryotes, eucaryotes, and organelles.

  1983cited by this paper
• Adenine phosphoribosyltransferase deficiency in cultured mouse mammary tumor FM3A cells resistant to 4-carbamoylimidazolium 5-olate.

  1982cited by this paper
• Cell cycle-dependent regulation of thymidine kinase activity introduced into mouse LMTK- cells by DNA and chromatin-mediated gene transfer.

  1981cited by this paper
• Selection of mammalian thymidine auxotrophic cell mutants defective in thymidylate synthase by their reduced sensitivity to methotrexate

  1981cited by this paper
• Cell cycle regulation of thymidylate synthetase gene expression in cultured mouse fibroblasts.

  1980cited by this paper
• Regulation of thymidylate synthetase in mouse leukemia cells (L1210).

  1980cited by this paper
• Comparison of the nucleic acid sequence of anglerfish and mammalian insulin mRNA's from cloned cDNA's.

  1980cited by this paper
• The structure and evolution of the two nonallelic rat preproinsulin genes.

  1979cited by this paper
• Globin mRNA sequences: analysis of base pairing and evolutionary implications.

  1978cited by this paper
• Animal cell cycle.

  1978cited by this paper
• DNA sequencing with chain-terminating inhibitors.

  1977cited by this paper
• Regulation of thymidylate synthetase activity in cultured mammalian cells.

  1972cited by this paper
• The periodic synthesis of thymidine kinase in mouse fibroblasts.

  1966cited by this paper

• Severe toxicity in adult patients with lung cancer under treatment with pemetrexed: a prospective cohort study

  2019cites this paper
• Prevalence of thymidylate synthase gene 5'-untranslated region variants in an Argentinean sample.

  2017cites this paper
• Molecular Biology: Are We Getting Any Closer to Providing Clinically Useful Information?

  2017cites this paper
• Prediction of severe toxicity in adult patients under treatment with 5-fluorouracil: a prospective cohort study

  2017cites this paper
• High frequency of the 3R/3R polymorphism in the thymidylate synthase enhancer region in Indonesian childhood acute lymphoblastic leukemia

  2016cites this paper
• Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase, dietary folate intake, and the risk of leukemia in adults

  2016cites this paper
• Role of pharmacogenetics for the improvement of cancer treatment

  2016cites this paper
• Genetic variant rs16430 6bp > 0bp at the microRNA‐binding site in TYMS and risk of sporadic breast cancer risk in non‐hispanic white women aged ≤55 years

  2015cites this paper
• Thymidylate synthase polymorphism in sporadic colorectal and gastric cancer in Tunisian population: a predictive role in 5-fluorouracil based chemotherapy treatment

  2014cites this paper
• Folate: metabolism, genes, polymorphisms and the associated diseases.

  2014cites this paper
• Tyms double (2R) and triple repeat (3R) confers risk for human oral squamous cell carcinoma

  2014cites this paper
• Immunology of Hematopoietic Stem Cell Transplant

  2014cites this paper
• Thymidylate synthase polymorphisms are associated to therapeutic outcome of advanced non-small cell lung cancer patients treated with platinum-based chemotherapy

  2014cites this paper
• Découverte de nouveaux marqueurs pharmacogénomiques de la maladie du greffon contre l'hôte en transplantation de cellules souches hématopoïétiques

  2014cites this paper
• Evaluating Predictive Pharmacogenetic Signatures of Adverse Events in Colorectal Cancer Patients Treated with Fluoropyrimidines

  2013cites this paper
• Genomic studies of GVHD—lessons learned thus far

  2013cites this paper
• MTHFR Glu429Ala and ERCC5 His46His Polymorphisms Are Associated with Prognosis in Colorectal Cancer Patients: Analysis of Two Independent Cohorts from Newfoundland

  2013cites this paper
• Overexpression of thymidylate synthetase confers an independent prognostic indicator in nasopharyngeal carcinoma.

  2013cites this paper
• Prediction of Chemotherapy Toxicities

  2013cites this paper
• Molecular markers for targeted neoadjuvant rectal cancer therapy

  2013cites this paper
• Pharmacogenomics and Personalized Medicine for Cancer

  2013cites this paper
• leukemia hydroxymethyltransferase genes and risk of adult acute lymphocytic Polymorphisms in the thymidylate synthase and serine

  2013cites this paper
• Thymidylate synthase genetic polymorphisms and cancer risk: a meta-analysis of 37 case-control studies.

  2012cites this paper
• Thymidylate Synthase 5’ UTR Polymorphic Allele Distribution in South Florida Population

  2012cites this paper
• Analysis of Polymorphisms and Haplotype Structure of the Human Thymidylate Synthase Genetic Region: A Tool for Pharmacogenetic Studies

  2012cites this paper
• Functional polymorphisms of folate metabolism and response to chemotherapy for colorectal cancer, a systematic review and meta-analysis

  2012cites this paper
• TS gene tandem repeats in esophageal cancer patients receiving chemoradiotherapy.

  2011cites this paper
• Modulatory effect of plasma folate and polymorphisms in one-carbon metabolism on catecholamine methyltransferase (COMT) H108L associated oxidative DNA damage and breast cancer risk.

  2011cites this paper
• Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategies.

  2011cites this paper
• The presence of three repeats in the 5' UTR region of thymidylate synthase (TS) is associated with increased TS mRNA expression in cultured human cancer cell lines in vitro.

  2011cites this paper
• Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer

  2011cites this paper
• Reexamining a proposal

  2011influential citation
• Determinants of antifolate and 5-fluorouracil efficacy

  2011cites this paper
• Association of thymidylate synthase enhancer region polymorphisms with thymidylate synthase activity in vivo

  2011cites this paper
• Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil.

  2011cites this paper
• Part 4: pharmacogenetic variability in anticancer pharmacodynamic drug effects.

  2011cites this paper
• Caractérisation pharmacogénétique des facteurs de résistance et de toxicité de l'Oxaliplatine et de l'Irinotécan dans les tumeurs colorectales

  2010cites this paper
• Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase in squamous cell carcinoma and basal cell carcinoma of the skin.

  2010cites this paper
• Genetic variation in the folate metabolic pathway and risk of childhood leukemia.

  2010cites this paper
• Relationship of polymorphism of the tandem repeat sequence in the thymidylate synthase gene and the survival of stage III colorectal cancer patients receiving adjuvant 5‐flurouracil‐based chemotherapy

  2010cites this paper
• dbCPCO: a database of genetic markers tested for their predictive and prognostic value in colorectal cancer

  2010influential citation
• Analysis of the Thymidylate Synthase Gene Structure in Colorectal Cancer Patients and Its Possible Relation with the 5-Fluorouracil Drug Response

  2010cites this paper
• Detection of the G>C SNP and rare mutations in the 28-bp repeat of TYMS using gel-based capillary electrophoresis.

  2010cites this paper
• MTR polymorphic variant A2756G and retinoblastoma risk in Brazilian children

  2010cites this paper
• One-carbon metabolism and breast cancer: an epidemiological perspective.

  2009cites this paper
• Genetic Variability in Folate-Mediated One-Carbon Metabolism and Risk of Colorectal Neoplasia

  2009cites this paper
• Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population.

  2009influential citation
• Folate and Cancer: Epidemiological Perspective

  2009cites this paper
• Loss of heterozygosity at thymidylate synthase locus in Barrett's metaplasia, dysplasia, and carcinoma sequences

  2009cites this paper
• Immunoregulatory gene polymorphisms and graft-versus-host disease

  2009cites this paper
• Association between polymorphisms of folate-metabolizing enzymes and hematological malignancies.

  2009cites this paper
• Effect of HIF-1 modulation on the response of two- and three-dimensional cultures of human colon cancer cells to 5-fluorouracil.

  2009cites this paper
• Pharmacogenetics of fluoropyrimidine and cisplatin. A future application to gastric cancer treatment

  2009cites this paper
• Thymidylate synthase gene polymorphisms effecting 5-FU response in breast cancer patients

  2009cites this paper
• Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancer.

  2009cites this paper
• Thymidylate synthase polymorphisms and mRNA expression are independent chemotherapy predictive markers in esophageal adenocarcinoma patients.

  2008cites this paper
• Predictive factors for chemotherapy-related toxic effects in patients with colorectal cancer

  2008cites this paper
• Thymidylate Synthase andMethylenetetrahydrofolate Reductase Gene Polymorphisms and Toxicity to Capecitabine in Advanced Colorectal Cancer Patients

  2008influential citation
• Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism

  2008cites this paper
• Thymidylate Synthase and Methylenetetrahydrofolate Reductase Gene Polymorphisms and Toxicity to Capecitabine in Advanced Colorectal Cancer Patients

  2008influential citation
• Identification and characterization of a novel thymidylate synthase from deep-sea thermophilic bacteriophage Geobacillus virus E2

  2008cites this paper
• DNA Polymorphisms Affecting Chemosensitivity Toward Drugs

  2008cites this paper
• Association between folate‐metabolizing pathway polymorphism and non‐Hodgkin lymphoma

  2008influential citation
• CANCER DRUG DISCOVERY AND DEVELOPMENT

  2007cites this paper
• Functional polymorphism of thymidylate synthase, but not of the COMT and IL‐1B genes, is associated with breast cancer

  2007cites this paper
• Prediction of efficacy and side effects of chemotherapy in colorectal cancer.

  2007cites this paper
• Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma

  2007cites this paper
• Identification of a novel single nucleotide polymorphism in the first tandem repeat sequence of the thymidylate synthase 2R allele

  2007cites this paper
• Polymorphisms involved in the folate metabolizing pathway and risk of multiple myeloma

  2007cites this paper
• Gene – gene interactions in the folate metabolic pathway influence the risk for acute lymphoblastic leukemia in children

  2007cites this paper
• Classification of thymidylate synthase gene enhancer region polymorphisms

  2007cites this paper
• Altered deoxyuridine and thymidine in plasma following capecitabine treatment in colorectal cancer patients.

  2007cites this paper
• G>C SNP of thymidylate synthase with respect to colorectal cancer.

  2007cites this paper
• Reply to the letter to the editor “Classification of thymidylate synthase gene enhancer region polymorphisms”

  2007cites this paper
• The thymidylate synthase tandem repeat promoter polymorphism: A predictor for tumor‐related survival in neoadjuvant treated locally advanced gastric cancer

  2006cites this paper
• Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia.

  2006cites this paper
• Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation.

  2006cites this paper
• Pharmacogenomics and colorectal cancer.

  2006cites this paper
• Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-versus-host disease following hematopoietic cell transplantation for chronic myelogenous leukemia.

  2006cites this paper
• Genetic variability in folate-mediated one-carbon metabolism and cancer risk

  2006cites this paper
• Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas.

  2006cites this paper
• Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment.

  2006cites this paper
• Genomic copy number changes affecting the thymidylate synthase (TYMS) gene in cancer: a model for patient classification to aid fluoropyrimidine therapy.

  2006cites this paper
• Genetic variation in genes of folate metabolism and neural-tube defect risk*

  2006cites this paper
• Thymidylate Synthase Messenger RNA Expression in Plasma from Patients with Colon Cancer: Prognostic Potential

  2006cites this paper
• Polymorphisms of 5,10-methylenetetrahydrofolate reductase (MTHFR C677T) and thymidylate synthase enhancer region (TSER) as a risk factor of cholangiocarcinoma in a Korean population.

  2006cites this paper
• Molecular biomarkers for the study of childhood leukemia.

  2005cites this paper
• Pharmacogenetics for individualized cancer chemotherapy.

  2005cites this paper
• Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers.

  2005cites this paper
• Thymidylate synthase pharmacogenetics

  2005cites this paper
• Thymidilate Synthase Polymorphisms in Indonesian Childhood Acute Lymphoblastic Leukemia

  2005cites this paper
• CONTINUING EDUCATION IN ONCOLOGY Basics of cancer pharmacogenomics

  2005cites this paper
• Pharmacological Modulation of Fluoropyrimidines

  2005cites this paper
• Risk of Non–Hodgkin Lymphoma Associated with Polymorphisms in Folate-Metabolizing Genes

  2005cites this paper
• A Phase I Pharmacologic and Pharmacogenetic Trial of Sequential 24-Hour Infusion of Irinotecan Followed by Leucovorin and a 48-Hour Infusion of Fluorouracil in Adult Patients with Solid Tumors

  2005cites this paper
• Relationship Between Thymidylate Synthase (TS) Genotype and TS Expression: A Tissue Microarray Analysis of Colorectal Cancers

  2005influential citation
• Individualized chemotherapy based on genetic and genomic profiling

  2005cites this paper
• Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents

  2005cites this paper
• Pharmacogenetics of folate-related drug targets in cancer treatment.

  2005cites this paper
• One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan.

  2005cites this paper